Search details
1.
Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study.
Lancet Oncol
; 24(7): 744-756, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37329891
2.
Phase Ib Study of Ulixertinib Plus Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Adenocarcinoma.
Oncologist
; 28(2): e115-e123, 2023 02 08.
Article
in English
| MEDLINE | ID: mdl-36427020
3.
Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma.
Oncology (Williston Park)
; 37(4): 176-183, 2023 04 25.
Article
in English
| MEDLINE | ID: mdl-37104758
4.
Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial.
Lancet Oncol
; 23(2): 279-291, 2022 02.
Article
in English
| MEDLINE | ID: mdl-35033226
5.
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(2): 167-192, 2022 02.
Article
in English
| MEDLINE | ID: mdl-35130500
6.
Race and ethnicity representation in clinical trials: findings from a literature review of Phase I oncology trials.
Future Oncol
; 17(24): 3271-3280, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-34047192
7.
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial.
Lancet Oncol
; 21(8): 1066-1076, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32653053
8.
Tolerability and safety of EUS-injected adenovirus-mediated double-suicide gene therapy with chemotherapy in locally advanced pancreatic cancer: a phase 1 trial.
Gastrointest Endosc
; 92(5): 1044-1052.e1, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32084409
9.
Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive gastric cancer: a dose-expansion, phase 1 study.
Lancet Oncol
; 20(6): 827-836, 2019 06.
Article
in English
| MEDLINE | ID: mdl-31047804
10.
Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study.
Lancet Oncol
; 20(6): 816-826, 2019 06.
Article
in English
| MEDLINE | ID: mdl-31047803
11.
Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation Burden.
Oncologist
; 24(2): 219-228, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30108156
12.
Randomized controlled trial of high-dose versus standard-dose vitamin D3 for prevention of aromatase inhibitor-induced arthralgia.
Breast Cancer Res Treat
; 177(2): 427-435, 2019 Sep.
Article
in English
| MEDLINE | ID: mdl-31218477
13.
Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 17(7): 855-883, 2019 07 01.
Article
in English
| MEDLINE | ID: mdl-31319389
14.
Multi-omic characterization of laboratory-evolved Saccharomyces cerevisiae HJ7-14 with high ability of algae-based ethanol production.
Appl Microbiol Biotechnol
; 102(20): 8989-9002, 2018 Oct.
Article
in English
| MEDLINE | ID: mdl-30121750
15.
Expression of a mutated SPT15 gene in Saccharomyces cerevisiae enhances both cell growth and ethanol production in microaerobic batch, fed-batch, and simultaneous saccharification and fermentations.
Appl Microbiol Biotechnol
; 101(9): 3567-3575, 2017 May.
Article
in English
| MEDLINE | ID: mdl-28168313
16.
Progress in PD-1-based Immunotherapy: New Mechanistic Insight May Provide Expanded Hope for Application to Colon and Gastrointestinal Cancers.
Gastroenterology
; 153(4): 1162-1163, 2017 10.
Article
in English
| MEDLINE | ID: mdl-28867277
17.
A Pilot Study of Paricalcitol plus Nanoliposomal Irinotecan and 5-FU/LV in Advanced Pancreatic Cancer Patients after Progression on Gemcitabine-Based Therapy.
Clin Cancer Res
; 29(23): 4733-4739, 2023 12 01.
Article
in English
| MEDLINE | ID: mdl-37801295
18.
Chemotherapy and Immune Checkpoint Blockade for Gastric and Gastroesophageal Junction Adenocarcinoma.
JAMA Oncol
; 9(12): 1702-1707, 2023 Dec 01.
Article
in English
| MEDLINE | ID: mdl-37856106
19.
Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targeting.
PLoS One
; 18(12): e0293700, 2023.
Article
in English
| MEDLINE | ID: mdl-38117806
20.
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline.
J Clin Oncol
; 41(7): 1470-1491, 2023 03 01.
Article
in English
| MEDLINE | ID: mdl-36603169